Skip to content

Topiramate and propranolol in migraine of children

Comparison of efficacy of topiramate and propranolol in prophylaxis of migraine headache in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201111282639N6
Enrollment
80
Registered
2011-12-05
Start date
2011-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine headache. Migraine without aura [common migraine]

Interventions

Intervention 1: 5mg/kg/day of oral topiramate for three months. Intervention 2: 1mg/kg/day of oral propranolol for three months.
Prevention
5mg/kg/day of oral topiramate for three months
1mg/kg/day of oral propranolol for three months

Sponsors

Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 15 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. children aged 5-15 years 2. Having migraine headache based on International Headache Society Criteria 3. Having also at least two episode of migraine headache in one month 4. No previous prophylactic therapy Exclusion Criteria: 1. History of drug allergy 2. Secondary headaches such as epilepsy or other neurologic disorders 3. Systemic diseases such as asthma, diabetes mellitus , metabolic acidosis , renal stone and hepatic diseases

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Number of headache in a month. Timepoint: before and three months after treatment . Method of measurement: asking from patient.;Pediatric disability score of migraine headache. Timepoint: before and three months after treatment . Method of measurement: asking from patient.;Severity of headache. Timepoint: before and three months after treatment . Method of measurement: asking from patient.

Secondary

MeasureTime frame
Side effect. Timepoint: monthly until three months after treatment. Method of measurement: clinical exam.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026